GVBL Q1 FY26-27 results: revenue drops 58% YoY but margins improve

Revenue declinedEBITDA margin expansionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.8%Reaction day

₹30.40

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-2.9% vs market

Pharmaceuticals & Biotechnology peers, median of 172sector · industry level-0.4%-2.4% vs sector

On the reaction day the stock moved 2.9 pts less than Nifty Microcap 250 and 2.4 pts less than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.8+0.1-2.9-0.4-2.4

Next day

-3.0+0.5-3.5-0.0-2.9

-2.9-0.1-2.8-0.8-2.2

+0.3+0.4-0.1-0.6+0.9

+0.0+0.7-0.7-0.9+0.9

—+0.9—-0.6—

-0.6+1.1-1.7-0.9+0.3

15d

-1.7+1.6-3.3+1.2-2.9

-0.5-0.7+0.2+0.4-0.9

+7.2-3.2+10.4-4.6+11.8

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals & Biotechnology peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

GVBL reported Q1 FY26-27 revenue of Rs 3.80 lakh, down 57.8% YoY from Rs 9 lakh in Q1 FY25-26. Total expenses fell to Rs 2.34 lakh from Rs 6.53 lakh. PAT stood at Rs 1.46 lakh vs Rs 2.47 lakh YoY, EPS at Rs 0.05 vs Rs 0.08. Sequentially, PAT recovered from a loss of Rs 0.82 lakh in Q4 FY25-26. EBITDA margin improved to about 40.5% from 28.3% YoY on lower costs. Auditor issued an unmodified limited review report.

Likely market impact

Mixed signals: sharp revenue decline YoY but better margins and sequential PAT recovery. Very small base limits meaningful comparison.